The IMV Technologies Group is a leader in the areas of animal and human-assisted reproduction technologies and veterinary imaging. IMV Technologies provides customers with solutions for animal artificial insemination; its human division, Cryo Bio System, offers solutions for human assisted reproduction including human embryo vitrification, human sperm freezing and preservation and other assisted reproduction technologies. The IMV imaging business provides customers with veterinary imaging solutions.
IMV Technologies
IMV Technologies was founded in 1963 by the inventor of the bovine artificial insemination straw, Mr. Robert Cassou. It is today an international company with subsidiaries in 8 countries. Today, IMV Technologies is involved in every step of the breeding process for farm animals, including in cattle, swine, equine, small ruminants, fish (primarily salmonids) and other species. We sell products used from semen collection to pregnancy diagnosis.
Areas of expertise
IMV Technologies provides animal artificial insemination and embryo transfer centers, veterinarians, and breeders with equipment and consumables, as well as education, to help them in their daily work. We are happy to be able to provide our customers with products for all species, including bovine, swine, poultry, equine, sheep, goats, rabbits, fish, and dogs, allowing them to collect, analyse, prepare, package, cryopreserve and store semen, as well as inseminate and check their animals for pregnancy. We are particularly keen to support our customers on a daily basis, for the use of our products, but also to help them develop their skills.
History
After creating the first French AI center for cattle in 1946, Robert Cassou founded IMV ("Instruments de Médecine Vétérinaire") in 1963. Since 1980, the group has reinforced its international presence by opening subsidiaries in the United States, India, China, Italy, the Netherlands, Russia, Scotland, and Brazil. Beyond the global expansion of the company, our history is full of a long series of innovations, including consumables, solutions to automate technicians' work in AI centers and in biobanks, as well as the creation of new preservation media or cryopreservation solutions.